The 2018 ESC/ESH hypertension guidelines: Should nephrologists always stop at the lower boundary?

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

(2018) Paul K. Whelton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Preserving kidney health during intensive blood pressure control

(2018) Maria Luisa S. Sequeira-Lopez et al.   Nature Reviews Nephrology

Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials

(2018) Srinivasan Beddhu et al.   Lancet Diabetes & Endocrinology

Target blood pressure and kidney protection

(2018) Giuseppe Mancia   Lancet Diabetes & Endocrinology

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Risk–benefit profile of intensive blood pressure treatment

(2018) João Sérgio Neves et al.   Lancet Diabetes & Endocrinology

Effects of Intensive BP Control in CKD

(2017) Alfred K. Cheung et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

When is a meta-analysis conclusive? A guide to Trial Sequential Analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery

(2017) Pavel S. Roshanov et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease

(2017) Wan-Chuan Tsai et al.   JAMA Internal Medicine

Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5

(2017) Rakesh Malhotra et al.   JAMA Internal Medicine

Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline

(2014) Alberto Zanchetti et al.   JOURNAL OF HYPERTENSION

Impact of Achieved Blood Pressures on Mortality Risk and End-Stage Renal Disease Among a Large, Diverse Hypertension Population

(2014) John J. Sim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis

(2013) J. Lv et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013)   EUROPEAN HEART JOURNAL

2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

(2013) Paul A. James et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis

(2012) Bakhtawar K Mahmoodi et al.   LANCET

KDIGO clinical practice guidelines for bisphosphonate treatment in chronic kidney disease

(2011) Keng T. Woo et al.   KIDNEY INTERNATIONAL

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Blood Pressure Components and the Risk for End-Stage Renal Disease and Death in Chronic Kidney Disease

(2009) R. Agarwal   Clinical Journal of the American Society of Nephrology

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

(2007) Jørn Wetterslev et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY